🇺🇸 FDA
Patent

US 11969522

Use of immune modulators to improve nerve regeneration

granted A61KA61K31/36A61K31/395

Quick answer

US patent 11969522 (Use of immune modulators to improve nerve regeneration) held by The Board of Regents of the University of Texas System expires Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Apr 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/36, A61K31/395, A61K31/519, A61K31/5377